Lymphocyte subsets at baseline, during treatment, and 4 weeks after the end of treatment.

Box plot representation of counts of lymphocyte subpopulations before, during, and after treatment of 15 patients from 3 institutions. (A) CD20⁺/CD19⁺ lymphocytes. (B) CD5⁺/CD19⁺ lymphocytes. (C) The κ⁺ or λ⁺/CD19⁺ lymphocytes. (D) CD45⁺/CD7⁺ or CD3⁺lymphocytes. Indicated P values (Wilcoxon-Pratt test, 2-sided): (1) .022, (2) .0015, (3) .0005, (4) .083, (5) .065, (6) .014.